Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Lymphoid 1

Conditions

Lymphoma 2 Virus Diseases 1 Paraparesis, Tropical Spastic 1 Neuritis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Leukemia-Lymphoma, Adult T-Cell 1 Hepatitis B 1 HTLV-I Infections 1 Burkitt Lymphoma 1

Interventions

entecavir 3 Tenofovir 1 Lamivudine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hepatitis B × Tenofovir × Lymphoid × Clear all

NCT02186574 2019-12-12

Tenofovir to Prevent HBV Reactivation

University Health Network, Toronto

Phase 3 Unknown

Hepatitis B, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡